Curaleaf Holdings Inc (CURA-CN) Quote - The Globe and Mail

Add to Watchlist Create Alerts

Delayed Last Update

Volume

Day Low4.8900

Day High5.1400

Open:5.0200

Previous Close

52-Week High/Low

Volume

Average Volume

Price/Earnings (TTM)

Forward Annual Dividend & Yield

Market Capitalization, $M

5-Day Change

the globe and mail

the globe and mail

U.S. cannabis reforms could send pot stocks higher

The reclassification of marijuana to a lower-risk Schedule III drug from Schedule I would allow cannabis companies to write off business expenses – a move that would boost cash flow and profits

October 11, 2023

Curaleaf Reports Third Quarter 2023 Results

November 9, 2023

Curaleaf to Report Third Quarter 2023 Financial and Operational Results

October 10, 2023

Curaleaf Applies to List Subordinate Voting Shares on the Toronto Stock Exchange

October 10, 2023

Curaleaf Announces Closing of C$16 Million Underwritten Offering of Subordinate Voting Shares

October 3, 2023

Curaleaf Expands Brand Portfolio With Launch of Zero Proof ™ Cannabis-Infused Drinkables

September 5, 2023

Curaleaf Celebrates Launch of Adult Use Sales at Manchester, CT Dispensary

August 21, 2023

Curaleaf's Select™ Brand Expands Product Offerings With Launch of Select Liquid Diamonds

August 10, 2023

Curaleaf Reports Second Quarter 2023 Results

Curaleaf to Report Second Quarter 2023 Financial and Operational Results

Curaleaf Celebrates Nationwide Launch of New Mobile App

Curaleaf Unveils Strategic National Rebrand of Select™

Curaleaf Celebrates Launch of Adult Use Sales at Groton, CT Dispensary

Curaleaf Holdings, Inc. Announcement Regarding Market Rumors

Curaleaf International Subsidiary to Acquire Clever Leaves' EU-GMP Certified Processing Facility in Portugal

Curaleaf Celebrates Launch of Adult Use Cannabis Sales in Maryland

Curaleaf Reports First Quarter 2023 Results

Curaleaf to Report First Quarter 2023 Financial and Operational Results

Curaleaf Announces May Conference Participation

Curaleaf Reports Fourth Quarter and Fiscal Year End 2022 Results

Curaleaf to Report Fourth Quarter and Fiscal Year End 2022 Financial and Operational Results

Curaleaf to Restate Certain Previously Issued 2022 and 2021 Financial Statements

NJ CRC Board Reverses Itself and Fully Approves Curaleaf's Adult Use License Renewals After Legal Challenge

CURALEAF COMMENTS ON NEW JERSEY CANNABIS REGULATORY COMMISSION'S BOARD DECISION

Curaleaf Continues Retail and Brand Expansions in Florida

The Global Cannabis Pharmaceuticals Market Size Is Expected To Surpass $125 Billion by 2028

Curaleaf Completes Acquisition of Deseret Wellness

Curaleaf Announces Acquisition of Deseret Wellness

Curaleaf Expands Brand Portfolio with Launch of JAMS™ Cannabis-Infused Edibles

Curaleaf Provides Update on 2022 Fourth Quarter and Full-Year Earnings Release and Earnings Call

Stocks in play: Curaleaf Holdings Inc

Curaleaf and Fab 5 Freddy Launch B Noble Cannabis Brand in Florida

Curaleaf to Report Fourth Quarter and Fiscal Year End 2022 Financial and Operational Results

Profile

Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the U.S. The company has operations in 19 states. Its brands include Curaleaf, UKU, Select, and Grassroots. The company acquired EMMAC Life Sciences in March 2021, beginning its foray into the global medical market in competition with Canadian cannabis producers.